Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'24
  • Budget'26 Budget'25 Budget'24
    • Home
    • News
    NSE IPO GMP Day 3 Issue Gets 5.67x Subscription GMP Falls to 2 percent

    NSE IPO GMP Day 3: Issue Gets 5.67x Subscription, GMP Falls to 2%


    Finance Outlook India Team | Monday, 21 September 2026

    NSE IPO GMP fell to around Rs 30, or nearly 2%, on September 21 as the Rs 22,569 crore NSE IPO concluded its three-day bidding period. The grey market premium indicated an estimated listing price of around Rs 1,815 per share against the upper price band of Rs 1,785.

    Key Highlights

    • NSE IPO received 5.67x subscription on the final bidding day, led by strong demand from qualified institutional buyers.
    • NSE IPO GMP fell to around 2%, indicating an estimated listing price near Rs 1,815 per share.

    The IPO received strong demand on its final bidding day, with qualified institutional buyers (QIBs) driving subscriptions. The issue was subscribed 5.67 times overall, while the retail portion saw comparatively lower participation.

    NSE IPO Subscription Status on Day 3

    At the close of bidding, the NSE IPO recorded the following subscription levels:

    Investor Category

    Subscription

    Qualified Institutional Buyers (QIBs)

    12.68x

    Non-Institutional Investors (NIIs)

    6.54x

    Retail Individual Investors (RIIs)

    1.33x

    Overall

    5.67x

    The strong QIB participation was the key contributor to the overall subscription, while retail demand remained relatively moderate.

    NSE IPO Details

    The Rs 22,569 crore NSE IPO is entirely an offer for sale (OFS) involving 12.64 crore shares. Since there is no fresh issue component, NSE will not receive any proceeds from the offering. The funds will go to the selling shareholders.

    The IPO price band was fixed at Rs 1,700-Rs 1,785 per share, with a lot size of eight shares. At the upper price band, the minimum retail investment stood at Rs 14,280.

    The post-issue market capitalisation is estimated at around Rs 4,41,788 crore. NSE IPO allotment is expected to be finalised on September 22, while the shares are expected to list on the BSE on September 24.

    NSE IPO GMP and Expected Listing Price

    The grey market premium stood at around Rs 30 on the final bidding day, translating into a premium of about 1.68% over the upper price band.

    Based on the latest NSE IPO GMP, the indicative listing price works out to approximately Rs 1,815 per share. GMP is an unofficial market indicator and actual listing prices can differ from grey-market indications.

    NSE Market Leadership and Business Strength

    NSE has a vertically integrated market infrastructure platform comprising of trading, clearing and settlement, listing, market data and index services.

    As per the data from NSE on June 2026, the total number of unique registered investors is 132.4 million and the trading members of the exchange are 1,328. Listed entities are 3,005 and the NSE market capitalisation stands at around Rs 474.1 trillion.

    As of June 2026, the exchange held a commanding share in most segments having a market share of approximately 93% in the cash market, 99.7% in equity futures and 68.5% in equity options based on premium turnover.

    NSE IPO Financial Performance

    In FY26, NSE's revenue from operations was Rs 16,601 crore, whereas in FY25 it was Rs 17,141 crore. Profit after tax was Rs 10,302 crore in FY26 as compared to Rs 12,188 crore in FY25.

    In the first quarter, the revenue was Rs 4,560 crore and PAT was Rs 3,120 crore. Brokerage analysis pointed out the fact that the company posted good operating margins despite the drop in profit in FY26.

    The analysis reveals that at the top end of its price range at Rs 1,785, NSE sees valuation of around 42.9 times the FY26 earnings.

    NSE IPO Risks Investors Should Track

    Regulatory, valuation, cybersecurity and systemic risks were identified during the IPO analysis. NSE is vulnerable to potential cyber-attacks and possible disruptions in IT infrastructure as it is a technology-based exchange.

    It also has clearing counterparty and systemic risks when its clearing members become insolvent, experience liquidity constraints or operational failures.

    Transaction charges, especially in the derivatives segment, are also key to the exchange's revenue, and thus, significant factors in its business.

    Also Read: NSE IPO Opens Strong: 9% Bids in 15 Mins; Check GMP & Risks

    NSE IPO Listing and Allotment Dates

    With bidding now closed, the next key dates for investors are the allotment and listing. The NSE IPO allotment is expected to be finalised on September 22, 2026, while the shares are expected to list on the BSE on September 24, 2026.



    Read More:

    Stock Market Today: Sensex Gains 564 Points, Nifty Gains 4th Day

    Startup Funding Report: 17 Firms Raise $61.8 Mn in the Latest Week

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25